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Abstract
Background: Higher insulin-like growth factor (IGF)-1 and lower IGF binding protein (BP)-3 levels have been associated with
higher commoncancer risk, including breast cancer. Dietary factors, genetic polymorphisms, and the combination of both
may influence circulating IGF-1 and IGFBP-3 serum concentrations.
Methods: From September 2011 to July 2012, we collected demographic, reproductive and dietary data on 143 women ($
40 years). We genotyped IGF-1 rs1520220 and IGFBP-3 rs2854744 and measured circulating IGF-1 and IGFBP-3 levels in
serum. Covariance analyses were used to estimate the associations of serum levels of IGF-1 and IGFBP-3, and the molar ratio
of IGF-1to IGFBP-3 with IGF-1 rs1520220 and IGFBP-3 rs2854744 genotypes. We subsequently assessed the combined
influence of genetics and diet (daily intake of protein, fat and soy isoflavones) on IGF-1 and IGFBP-3 levels.
Results: Among women aged less than 50 years, circulating IGF-1 serum levels were significantly lower for those with CC
genotype for IGF-1 rs1520220 than levels for those with the GC or GG genotypes (in recessive model: P = 0.007).In gene-diet
analyses among these women, we found carrying CC genotype for IGF-1 rs1520220 and high soy isoflavone intake tend to
be associated with lower circulating IGF-1 levels synthetically (P = 0.002). Women with GG or GC genotypes for IGF-1
rs1520220 and with low intake of soy isoflavones had the highest levels of circulating IGF-1 (geometric mean [95% CI]: 195
[37, 1021] mg/L). Comparatively, women with both the CC genotype and high soy intake had the lowest levels of circulating
IGF-1 (geometric mean [95% CI]: 120 [38,378] mg/L).
Conclusions: IGF-1 serum levels are significantly lower among women with the CC genotype for IGF-1-rs1520220. High soy
isoflavone intake may interact with carrying CC genotype for IGF-1-rs1520220 to lower women’s serum IGF-1 levels more.
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Introduction
The insulin-like growth factor (IGF) -system mainly consists of
IGF-1, IGF-2, IGF receptors (IGF-1R and IGF-2R), and six
binding proteins (IGFBP-1-6). Within IGF system, IGF-1 and its
main binding protein, IGFBP-3, are two key molecules for cellular
proliferation, differentiation and apoptosis [1]. In addition to the
regulation of normal cell growth, IGF systems have been
implicated in carcinogenesis [2]. Results from in vivo carcinogen-
esis models and epidemiological studies indicate that high levels of
circulating IGF-1 are associated with increased risk and progres-
sion of several common cancers, including breast [3–7], prostate
[8–11], colorectal [12–15], and ovarian cancer [16–17] among
others. The relationship between circulating IGFBP-3 levels and
cancers have been inconsistent [14,16,18–22].
Circulating IGF-1 and IGFBP-3 levels are determined by both
heritable and exogenous factors. Two twin studies estimated that
approximately 40%–60% of inter-individual differences in circu-
lating levels of IGF-1 and IGFBP-3 are attributed to heritable
factors, such as single nucleotide polymorphisms (SNPs) [23–24].
Although there are many SNPs identified for IGF-1 (rs1520220,
rs10735380, rs5742665, rs1549593, rs2373722, etc.) and IGFBP-3
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genes (rs2854744, rs2854746, rs3110697, rs2132570, rs2270628,
etc.) [25], SNP rs1520220, located in the third intron of IGF-1
gene, and rs2854744, in the promoter region of the IGFBP3 gene,
are consistently found to be associated with circulating IGF-1 and
IGFBP-3 levels in Caucasians[26–29]. However, the associations
of both SNPs with circulating IGF-1 and IGFBP-3 levels is not
clear in the Chinese population as few studies have focused on this
population. Exogenous factors, including both hormonal and
nutritional, may have an important influence on circulating IGF-1
and IGFBP-3 levels [30]. Decreased levels of serum IGF-1 and
IGFBP-3 were observed after chronic or acute energy restriction
[31]. Several cross-sectional studies have found that serum IGF-1
concentrations are positively associated with higher total protein
intake [32–34]. Soy isoflavone, a phytoestrogen, may act as
selective ER modulators do by inhibiting IGF-1 concentrations or
IGF system signaling [35].
In our previous studies, we mainly focused on breast cancer
etiology and to be consistent with other studies in finding that
nutrients, for example animal protein [36–37] may increase breast
cancer risk, while high intake of soy products [38–39] may result in
risk reduction. Given the associations of SNPs and dietary intake
with circulating levels within the IGF system (IGF-1, IGFBP-3 and
the molar ratio of IGF-1 to IGFBP-3), the hypothesis that genetic
and nutritional factors may interact to effect serum concentrations
of the IGF system and subsequent cancer risk warrants further
investigation [30]. Several studies conducted among Caucasian
women have examined the effects of nutritional factors and IGF
polymorphisms on IGF serum levels [26,28,30,33–34]. However,
to the best of our knowledge, no previous study has examined this
issue in Chinese population in China, and previous studies did not
focus on the interaction of genetic and environmental factors. In
the present study, we examined the main effects of dietary intake
and genetic polymorphisms on circulating IGF-1 and IGFBP-3
concentrations among women aged 40 years or older, a population
with high breast cancer incidence in China (more than 42.3 per
100,000) [40]. Furthermore, we explored potential combined




The study protocol was approved by the Institutional Review
Board at Sichuan University. All subjects provided written
informed consent before completing the questionnaire survey
and laboratory tests.
Study population
From September 2011 to July 2012, a total of 279 women aged
40 years and older sought the outpatient service for a physical
examination from the Comprehensive Guidance Center of
Women’s Health, Chengdu Women’s and Children’s Central
Hospital. The women who were of Han ethnicity, had been living
in Sichuan Province for over 20 years, had no history of bilateral
ovariectomy, no hormonal contraceptive use, and no perimeno-
pausal complaints. We further excluded women who declined to
join the program, women with insulin-dependent diabetes
mellitus, and women with diagnosed/history of malignancy,
including breast, liver or ovarian cancer at baseline as these
diseases may affect circulating IGF levels. Ultimately, 143 women
were included in the study. To minimize possible impact of
estrogens from periodical variation during the menstrual cycle on
IGFs, all women were enrolled between the 3rd and 5th day from
the beginning of their periods for blood sample collection.
Data collection
Information on socio-demographic and reproductive character-
istics was collected using a structured questionnaire. A semi-
quantitative dietary questionnaire, the Questionnaire of Health
Related Dietary Habits, was designed to collect all participants’
long-term ($ 5 years) dietary habits. Evaluation of reliability and
structural validity for the questionnaire has been described in
detail in our previous study [39]. In brief, we first calculated the
total daily intake of energy, protein, fat, carbohydrate, dietary
fiber, and soy isoflavones referring to the nutrient compositions
listed in the Danone Institute China Diet Nutrition Evaluating
System [41]. We subsequently calculated the daily intake of
energy-adjusted dietary factors to prevent potential underreporting
of dietary intake using residual methods [39]. According to
Chinese Dietary Reference Intakes (DRI) (Chinese DRIs commit-
tee formulated in 2000) for 18–50 year old women with moderate
physical labor [42], we used the following dichotimization for total
daily energy (2300 kcal/day), protein (70 g/day) and fat intake
(77 g/day). For those without recommended levels of dietary
intake, the means of dietary intakes (167.0 g/day for carbohy-
drate, 19.8 g/day for dietary fiber and 11.6 mg/day for soy
isoflavones) were selected as cut-off values of high/low intake.
Genotype analyses
Whole blood samples (5 mL) were obtained from participants
via venipuncture into tubes containing ethylenediaminetetraacetic
acid. Samples were stored at 220uC until DNA extraction.
Genomic DNA was extracted from whole blood using TIANamp
Blood DNA Kit (TIANGEN, Beijing). IGF-1 rs1520220 and
IGFBP-3 rs2854744 were genotyped with TaqMan assays which
were purchased from ABI (Applied Biosystems, Foster City, CA).
All TaqMan assays were performed with the ABI 7500 thermal
cycler (Applied Biosystems, Foster City, CA). In addition,
duplicate detection was performed for 10 random samples (6%
of the total subjects), and the observed concordance rate was
100%.
Serum proteins measurement
A separate 3 mL of whole blood was withdrawn and then
transported immediately to the laboratory, where samples stood
for 2 hours, and then spun at 2500 g for 15 min, after which the
serum was extracted and stored at 270uC until analysis.
Circulating total IGF-1 and IGFBP-3 levels were measured
using enzyme-linked immunosorbent assay kits (Diagnostic Sys-
tems Laboratories, Webster, TX) according to manufacturers’
instructions. Duplicate aliquots from each blood sample were
analyzed for each individual, and the average of the two
measurements was used for data analyses. Coefficients of variation
(CVs) for duplication were less than 10%. The intra- and inter-
assay coefficients of variation were 4.1% and 12.8%, respectively,
for IGF-1 at a concentration of 110 ng/ml. Intra and inter-assay
coefficients of variation were 4.9% and 5.4%, respectively, for
IGFBP-3 at a concentration of 4,900 ng/ml. The molar ratio,
which may estimate the biologically active fraction of
IGF{1 : IGFBP{3 molar ratio~
(C1|0:130)=(C2|0:036)|1000
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IGF-1, was calculated based on equation 1:
C1 and C2 are concentrations of IGF-1 and IGFBP-3,
respectively. For IGF-1, 1 ng/ml is equal to 0.130 nM, and for
IGFBP-3, 1 ng/ml is equal to 0.036 nM.
To ensure blinded laboratory analyses, participants were
assigned a unique random ID number at each clinic visit.
Statistical analyses
We checked the Hardy–Weinberg equilibrium (HWE) among
all women via Chi-square test. The measured total IGF-1 and
IGFBP-3 levels were log transformed to reduce departures from
the normal distribution and then described using the geometric
mean (95% confidence interval [CI]). After making a scatter plot
of IGF component levels (i.e. IGF-1, IGFBP-3, and the molar ratio
of IGF-1 to IGFBP-3) by age, we found that IGF levels were
relatively more centralized among women aged less than 50 years.
Considering differences in sex steroid levels between two age
groups, which may affect circulating IGF levels, we divided the
participants into two subgroups for sub-group analyses: ,50 years
and $50 years. Independent-sample T-tests and Chi-square tests/
Fisher’s exact tests were used to compare the demographic
characteristics, and reproductive and dietary factors between age
subgroups. Independent-sample T-tests were used to compare
geometric means of IGF-1, IGFBP-3, and the molar ratio of IGF-1
to IGFBP-3 (equation 1), for each exposure of interest. Factors that
were significantly associated with IGF component levels were then
adjusted for as potential confounders in the covariance analyses to
test the differences of IGF component levels within gene-diet
exposure groups. Referring to results from previous studies that
noted carrying the CC genotype for IGF-1 rs1520220 was
associated with lower IGF-1 levels in breast tissue among Chinese
women [43], and that circulating levels of IGFBP-3 were
significantly lower for CC or CA genotype carriers for IGFBP-3
rs2854744 than AA allele carriers [44], we analyzed the effects
within the recessive model for IGF-1 rs1520220 (CC vs. GC+GG)
and IGFBP-3 rs2854744 mutant allele (AA vs. CC+CA) in IGF
component levels.
The data were input into a database created with Epidata3.1
and analyzed with SPSS18.0 software.
Results
General demographic characteristics, dietary intake, and
related reproductive factors
The demographic characteristics, reproductive and dietary
factors, and insulin-like growth factor levels of our population
were compared. We found no significant difference of these factors
between age subgroups of ,50 years and $50 years (Table 1).
Geometric mean (95% CI) of IGF-1 and IGFBP-3, and the
molar ratios for the participants are shown in Table 2 and
stratified by measures of dietary intake. Among all participants,
IGF-1 levels were positively correlated to both IGFBP-3 and the
molar ratio of IGF-1to IGFBP-3 (Spearman’s correlation coeffi-
cient: r = 0.44 and r = 0.70, respectively; both P,0.05). Average
daily intake of key nutrients among all study participants were as
follows (mean level6standard deviation [SD]): 1553.86591.7
kcal/day for energy intake, 65.0615.6 g/day for energy-adjusted
protein, 69.8624.4 g/day for fat, 167.0646.9 g/day for carbo-
hydrates, 19.866.9 g/day for dietary fiber, and 11.6615.8 mg/
day for soy isoflavones. While protein was not associated with any
IGF component among all women, we found borderline
significantly higher levels of IGFBP-3 among women with high
protein intake compared to women classified as having low intake
(P = 0.06) in the ,50 age group. We also found a higher molar
ratio of IGF-1 and IGFBP-3 for participants with high dietary
fiber consumption (P = 0.03) among women $50 years. Total
energy intake, daily intake of energy-adjusted fat, carbohydrate,
and soy isoflavone were not associated with serum levels of IGF
components.
Circulating levels of IGF components, stratified by demographic
and reproductive characteristics, are shown in Table S1. Among
women ,50 years, we observed weak negative associations
between WHR and circulating IGF-1 (P = 0.06). Passive smoking
was associated with higher circulating levels of IGF-1 with
borderline significance (P = 0.056). Age at menarche was positively
associated with IGF-1 levlels among women$50 years (P = 0.003).
While associations between active smoking, drinking, and IGF
components were of interest, small cell sizes (N = 2 and N = 4 for
smoking and drinking, respectively) limited our ability to test these
associations.
IGF-1 rs1520220/IGFBP-3 rs2854744 genotypes and
circulating IGF component levels
Among all women, the frequency of the C allele for IGF-1
rs1520220 and the C allele for IGFBP-3 rs2854744 were 56.6%
and 27.1%, respectively. Genotypes of IGF-1 rs1520220 and
IGFBP-3 rs2854744 did not deviate from HWE (IGF-1
rs1520220: x2 = 3.04, P = 0.08; IGFBP-3 rs2854744: x2 = 2.29,
P = 0.13). Table 3 presents covariance analyses results of IGF-1
rs1520220 and IGFBP-3 rs2854744 genotypes in relation to
circulating levels of IGF components. Among women ,50 years,
circulating IGF-1 levels were significantly lower for those carrying
the CC genotype for IGF-1 rs1520220 than IGF-1 levels for those
carrying GC or GG genotypes (recessive model: P = 0.007). We
did not observe any association between IGFBP-3 rs2854744
genotypes and circulating IGFBP-3 level or the molar ratio.
Combination of IGF-1 rs1520220/IGFBP-3 rs2854744
genotypes and daily intake of energy-adjusted soy
isoflavones and protein on circulating IGF component
levels among women ,50 years old
For women ,50 years, thosewith both low intake of soy
isoflavones and at least one variant G allele for IGF-1 rs1520220
had the highest levels of circulating IGF-1 (geometric mean [95%
CI]: 195 [37, 1021] mg/L). Women who either had high intake of
dietary soy or were homozygous for the major C allele had
significantly lower levels of circulating IGF-1 (geometric mean
[95% CI]: 160 [34, 753] mg/L and 167 [38, 723]mg/L,
respectively). Women who had both high soy intake and were
homozygous for the major C allele had the lowest levels of
circulating IGF-1 (geometric mean [95% CI]: 120 [38, 378] mg/L)
(Table 4, P = 0.002). As for combination of IGFBP-3 rs2854744
genotypes and soy isoflavone intake, we found higher IGFBP-3
levels inwomen with low soy intake (groups 1 and 2: (geometric
mean [95% CI]: 1832 [503, 6671] mg/L and 2014 [613, 6613]
mg/L, respectively)) than those women with high soy intake
(groups 3 and 4: (geometric mean [95% CI]: 1654 [663, 4124] mg/
L and 1735 [641, 4696] mg/L, respectively)), but these differences
appear to be driven primarily by soy intake, as the overall effect of
diet and genetics was not significant (P = 0.40). Although protein
intake were found to be related to IGF system variables (Table 2),
combinations of IGF-1 rs1520220/IGFBP-3 rs2854744 geno-
types and daily intake of energy-adjusted protein were not
associated with IGF component levels (P.0.05).
While dietary fiber intake seems to be positively related to the
molar ratio of IGF-1 to IGFBP-3 in the $50 age group (Table 2),
we did not analyze combinations of IGF-1 rs1520220/IGFBP-3
Genetic and Dietary Determinants of IGF Levels
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rs2854744 genotypes and dietary fiber intake due to limited
sample size in this age group.
Discussion
In this study, we aimed to reveal the genetic and dietary
determinants of IGF-1 and IGFBP-3 in our population of Chinese
women aged 40 years or older. We found that carrying CC
genotype for IGF-1 rs1520220 may work alone or interact with
high soy food intake to decrease serum IGF-1 levels among women
,50 years old.
Serum concentrations of IGF-1 and IGFBP-3 are mainly
determined by genetic factors [23-24]. Although SNP rs1520220
is located in the intron of IGF-1 gene, it may influence circulating
IGF-1 expression via altering the secondary structure of RNA[45]
or DNA [46]. In this study, we observed that IGF-1 levels for
carriers of CC genotype for IGF-1 rs1520220 were significantly
lower than that for G allele carriers. In another study, carrying CC
genotype for IGF-1 rs1520220 was associated with lower IGF-1
levels in breast tissue among 403 Chinese women [43], which is
similar to results of our study. Guet al. 2010 produced consistent
results from 5533 women and 5379 men that carrying the G allele
for IGF-1 rs1520220 was associated with increased IGF-1 levels
[29]. However, a previous study with 345 women from the United
Kingdom also examined the association between IGF-1 tagging
polymorphisms and circulating IGF-1 levels, and found that the C
allele for IGF-1 rs1520220 was associated with increased
circulating IGF-1 in 345 females [26]. The C to A mutation for
IGFBP-3 rs2854744 may theoretically result in reduced promoter
activity, and in turn, decreased levels of circulating IGFBP-3 [28].
This SNP has been found to be strongly associated with IGFBP-3
levels in several studies among Caucasian women [26-28];
however, we did not observe this association in our study. Our
lack of association may be due to the low frequency of the C allele
in our study population (27.1%) compared to Caucasian
populations (,53.0% in women) [47-48]. However, the observed
frequency of the C allele among women living in the Sichuan
province is similar to the frequency reported in a large population-
based study in Shanghai, China (23.0%) [49]. Therefore, we
believe that any discrepancies observed between our study and
those conducted among Caucasian women may be attributed to
racial diversity. In addition to genetic polymorphisms, dietary
factors may influence circulating IGF system levels in humans.
Several mechanisms have been proposed [30]: i. Approximately
80% of circulating IGF-1 are synthesized in the liver and
exogenous factors, such as diet, may directly influence hepatic
IGF-1 expression, synthesis, and secretion, resulting in altered
serum IGF levels; ii. Certain dietary factors (i.e. protein and fat
intake) could affect IGFBP levels, and may also influence the
binding ability of IGF-1 to IGF-1R by competing for active sites;
iii. Dietary factors may indirectly affect the IGF system through
interaction with genetic factors.
Soy food has consistently been characterized to have an
anticancer effect [50], particularly in Asian populations where
soy intake is relatively high. In vitro studies have shown that
pharmacological doses of genistein, the main composition of soy
isoflavones, may stimulate IGF-1R signaling human breast cancer
cells [51].Although we did not find associations between soy intake
and serum IGF-1 as previous studies did [52], we observed that
high soy intake enhanced the association between carrying CC
genotype for IGF-1 rs1520220 and lower circulating IGF-1 levels
among women aged ,50 years. Since relatively high circulating
IGF-1 concentration is associated with increased cancer risk [18-
19], modulation of IGF-1 levels by soy isoflavone intake may be
implemented as a risk reduction mechanism, particularly for breast
cancer as reported in our previous studies [38-39]. We also
hypothesized that IGFBP-3 polymorphisms may potentially
interact with dietary intake, for example, soy isoflavone intake,
Table 1. Descriptive statistics of demographic, reproductive and insulin-like growth factors by age status.
Variables ,50 years $50 years P valued
N statistical distribution N statistical distribution
BMI(kg/m2) b 103 22.262.5 38 22.462.6 0.72
WHR b 89 0.860.06 35 0.860.05 0.21
Age at menarche (years) b 103 13.561.4 37 13.961.5 0.08
Passive smoking, yes, n (%) 69 68.3 25 71.4 0.73
Parity, $2, n (%) 16 16.5 7 19.4 0.69
Breast feeding, $3 months, n (%) 75 75.0 22 71.0 0.66
Total energy intake (kcal/day) b 104 1566.46645.3 39 1520.16421.6 0.68
Protein intake (g/day)a, b 104 64.1617.1 39 67.4610.5 0.17
Fat intake (g/day)a, b 104 71.0625.9 39 66.5619.6 0.33
Carbohydrate intake (g/day)a, b 104 165.2649.0 39 171.7641.2 0.47
Dietary fiber intake(g/day)a, b 104 19.567.4 39 20.865.2 0.30
Soy isoflavone intake (mg/day)a, b 104 12.4617.7 39 9.568.3 0.32
Insulin-like growth factor-1 (mg/L)c 104 168.0 (36.2, 779.0) 39 200.3 (35.7, 1125.3) 0.25
Insulin-like growth factor binding
protein-3 (mg/L) c
104 1837.5 (594.6, 5678.9) 39 1669.2 (508.7, 5476.6) 0.38
IGF-1:IGFBP-3 molar ratio c 104 330.2(63.5,1716) 39 433.3(76.6,2451.6) 0.09
a: The dietary key nutrient intakes, including protein, fat, carbohydrates, dietary fiber, and soy isoflavones are adjusted for energy by residual method; b: mean 6
standard deviation;. c: Geometric mean (95% confidence internal); d: P value is based on T test for continuous variables and x2 test or Fisher’s exact test for categorical
variables. Waist to hip ratio, WHR; Body mass index, BMI.
doi:10.1371/journal.pone.0108934.t001
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Table 2. Relationship between geometric mean (95% CI) of insulin-like growth factor component levels with dietary intake.
Variables N IGF-1 (mg/L) IGFBP-3 (mg/L) IGF-1:IGFBP-3
Overall
Total energy intake (kcal/day) ,2300 130 181 (36,906) 1782(580,5476) 367 (67,2015)
$2300 13 134(36,498) 1874(469,7492) 258(66,1009)
P value 0.20 0.77 0.16
Protein intake (g/day) ,70 93 178(35,913) 1694(525,5467) 380(67,2161)
$70 50 173 (38,790) 1984 (679,5796) 315 (66,1499)
P value 0.85 0.12 0.22
Fat intake (g/day) ,77 100 182 (34,981) 1834 (585,5746) 359(65,1998)
$77 43 163 (42,633) 1692(534,5362) 348 (69,1757)
P value 0.45 0.45 0.85
Carbohydrate intake (g/day) ,167.0 70 163(35,756) 1747(577,5286) 337(64,1779)
$167.0 73 190 (37,978) 1833(561,5986) 375(68,2060)
P value 0.25 0.62 0.46
Dietary fiber intake(g/day) ,19.8 67 155(37,647) 1793 (548,5873) 312 (61,1608)
$19.8 76 197 (36,1078) 1787 (587,5439) 399(73,2180)
P value 0.07 0.97 0.09
Soy isoflavone intake (mg/day) ,11.6 90 193(36,1022) 1870 (541,6465) 372 (63,2193)
$11.6 53 151 (37,622) 1662(642,4303) 329(72,1504)
P value 0.09 0.21 0.39
,50 years
Total energy intake (kcal/day) ,2300 92 173 (37,816) 1840(617,5485) 340(64,1814)
$2300 12 133 (34,526) 1821(435,7620) 264(64,1086)
P value 0.28 0.95 0.33
Protein intake (g/day) ,70 68 163(38,711) 1700(542,5334) 346 (63,1917)
$70 36 178(34,934) 2129 (742,6111) 302(65,1392)
P value 0.59 0.06 0.43
Fat intake (g/day) ,77 68 176(34,905) 1924 (623,5944) 330 (59,1844)
$77 36 154(41,577) 1684 (547,5188) 330(72,1521)
P value 0.41 0.26 0.99
Carbohydrate intake (g/day) ,167.0 55 158(34,724) 1774 (581,5421) 321 (67,1552)
$167.0 49 180 (38,849) 1911 (607,6022) 341(60,1942)
P value 0.39 0.51 0.72
Dietary fiber intake(g/day) ,19.8 54 153 (35,667) 1734(508,5917) 319 (65,1575)
$19.8 50 186(38,911) 1957(714,5363) 342 (62,1905)
P value 0.22 0.29 0.68
Soy isoflavone intake (mg/day) ,11.6 63 184 (38,889) 1934(567,6600) 344(64,1847)
$11.6 41 146 (34,620) 1699(657,4393) 311(62,1551)
P value 0.14 0.26 0.55
$50 years
Total energy intake (kcal/day) ,2300 38 202 (35,1158) 1649(499,5445) 443(78,2512)
$2300 1 140 2650 191
P value – – –
Protein intake (g/day) ,70 25 226(32,1618) 1677 (471,5971) 486 (84,2821)
$70 14 162(53,496) 1655 (567,4835) 353(66,1879)
P value 0.19 0.95 0.28
Fat intake (g/day) ,77 32 196 (33,1180) 1656 (517,5305) 428(79,2310)
$77 7 220(50,968) 1729 (431,6945) 459(58,3662)
P value 0.76 0.87 0.85
Carbohydrate intake (g/day) ,167.0 15 183(36,917) 1648 (548,4962) 400(55,2905)
$167.0 24 212 (35,1306) 1682 (476,5943) 456(93,2244)
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and then influence circulating IGF component levels. However,
we found negative results, which may be due partly to the limited
sample in our study. This hypothesis deserves further study with a
larger sample size.
Total energy and dietary protein have been shown to be
positively associated with serum IGF levels [32–34]. We observed
no associations between total energy and IGF component levels,
although there was a borderline significant positive association for
dietary protein and IGFBP-3, it was limited to women aged ,50
years (Table 2). In this age group, positive results disappeared
when we combined protein intake and IGF-1 rs1520220/IGFBP-
3 rs2854744 genotypes. Few studies paid attention to the
relationship of dietary fiber intake and circulating IGF levels.
Gannet al. 2005 found low fat, high fiber dietary intake didn’t
change circulatory IGF-1 or IGFBP-3 levels compared to the usual
diet among women in Chicago after a intervention period of 12
menstrual cycles [53]. However, the main effect of dietary fiber
intake isn’t clear yet. In our study, while we observed a possible
relationship of high dietary fiber intake with increased molar ratio
of IGF-1 to IGFBP-3 in the $50 age group, relativaely limited
sample (N = 39) may have limited our ability to ascertain the
association of dietary fiber intake combined with IGF-1
rs1520220/IGFBP-3 rs2854744 genotypes with IGF component
levels. We believe that the effects of fiber intake on IGF system
Table 2. Cont.
Variables N IGF-1 (mg/L) IGFBP-3 (mg/L) IGF-1:IGFBP-3
P value 0.61 0.92 0.66
Dietary fiber intake(g/day) ,19.8 13 162 (45,590) 2063 (765,5565) 284(44,1838)
$19.8 26 223(33,1482) 1501 (434,5190) 535 (116,2483)
P value 0.30 0.12 0.03
Soy isoflavone intake (mg/day) ,11.6 27 215(33,1411) 1730(481,6219) 449(64,3170)
$11.6 12 171(45,647) 1541(576,4120) 401(128,1255)
P value 0.46 0.59 0.66
Insulin-like Growth Factor, IGF; Insulin-like Growth Factor Binding Protein, IGFBP; P value is based on T test.
doi:10.1371/journal.pone.0108934.t002
Table 3. Relationship between geometric mean (95% CI) of insulin-like growth factor component levels with IGF-1 and IGFBP-3
genotypes.
Variables N IGF-1 (mg/L) IGFBP-3 (mg/L) IGF-1:IGFBP-3
Overall
IGF-1 GG+ CG 92 191 (35,1039) 1819(574,5765) 380(68,2115)
CC 51 152(39,589) 1738(558,5412) 316(63,1576)
P value 0.10 0.66 0.22
IGFBP-3 CC+CA 63 161(35,731) 1723(566,5251) 337(57,2009)
AA 79 187 (36,963) 1838(567,5957) 368(74,1831)
P value 0.23 0.70 0.57
,50 yearsa
IGF-1 GG+ CG 66 180(36,8980) 1907(634,5731) 341(61,1900)
CC 38 149 (37,597) 1724(530,5605) 313(67,1450)
P value 0.007 0.16 0.46
IGFBP-3 CC+CA 45 164 (34,800) 1759(558,5546) 337(55,2075)
AA 59 171 (38,773) 1900(621,5812) 325 (71,1489)
P value 0.76 0.44 0.80
$50 yearsb
IGF-1 GG+ CG 26 224(34,1478) 1616(454,5754) 501(99,2534)
CC 13 160 (44,591) 1781(629,5044) 325(50,2116)
P value 0.29 0.97 0.25
IGFBP-3 CC+CA 18 153(39,597) 1638(575,4670) 337 (59,1945)
AA 20 244(36,1667) 1666(434,6396) 528(99,2823)
P value 0.14 0.85 0.25
Insulin-like Growth Factor, IGF; Insulin-like Growth Factor Binding Protein, IGFBP.
a: Models among women ,50 years were adjusted for WHR (waist hip ratio), passive smoking and protein intake; b: Models among women $50 years were adjusted for
age at menarche and dietary fiber intake.
doi:10.1371/journal.pone.0108934.t003
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levels and corresponding cancer risk deserve further study.To our
knowledge, our study is the first to explore the combined-
influence of IGF-1 rs1520220/IGFBP-3 rs2854744 and dietary
factors on IGF component levels. Although it is a cross-sectional
study among hospital-based women, with limited sample size, we
only selected the women who sought a physical examination and
not those who suffering from any disease that may affect
circulating IGF levels; we also implemented strict quality control
measures throughout the study, including data collection, labora-
tory tests and statistical analyses. Thus, we believe our findings
reflect the correlation between IGF-1 rs1520220/IGFBP-3
rs2854744, dietary intake, and IGF levels in the general
population of Chinese women aged 40 years and older. In
addition, the observed combined influence of soy isoflavone
consumption and IGF-1 rs1520220 genotypes on IGF-1levels may
reflect some underlying biological interaction of the IGF-1 gene
and diet on serum IGF component levels. This requires
confirmation in larger prospective studies. A randomized control
trial of soy isoflavone supplements would aid our understanding of
these interactions and help expose the anticancer mechanism of
soy isoflavones.
Supporting Information
Table S1 Associations between general demographic, reproduc-
tive factors and circulating IGF components levels.
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